Private Placement
July 2024

411 University St, Seattle
Numus Capital is an Exempt Market Dealer which supports the issuers partnered with Numus Financial. The firm is licensed to sell investment securities that are exempt from prospectus requirements based on rules and regulations in the provinces under which Numus is registered. Numus Capital can provide accredited or exempt investors with access to early-stage investment opportunities.
Numus Capital regularly completes private placements for private issuers, concurrent financings for issuers at the time of listing, and financing for listed issuers to secure funding to accelerate on-going growth. Numus Capital also acts as an agent for issuers in transactional matters, joint venture partnerships and mergers and acquisitions.
Numus Capital investors have access to high-risk/high-reward investment opportunities frequently associated with the exempt markets.
It all starts with the KYC (Know-Your-Client). We collect information on you, your financial background and your current investment strategy. Once we know more about you, and based on your financial objectives, we will bring relevant investment opportunities to you when they arise. You assess each opportunity on its merits to determine which investments you are interested in participating. Post investment you can follow the progress of your investments through news releases, social media and quarterly newsletters. Numus will set you up to keep track of your investments over time.
No, Numus does not offer client accounts. So should you choose to invest, Numus will coordinate your investment directly with the company offering the investment. All investments are funded directly towards the company and not paid to Numus.
Although we do not have a firm minimum investment size as long as the investor is accredited, we typically do not onboard individuals looking to invest under $20k.
Since we do not hold assets on behalf of clients, clients invest directly with the issuers. Upon closing, we will send you either a share certificate or DRS statement so you can deposit your shares into a brokerage account.
Since Numus private placements are exempt of prospectus requirements, all private placements are subject to a four month plus one day holding restriction as per Canadian securities laws.
Numus company principals have an extensive successful track record in raising capital for both private and public companies. Principals have completed deals valued in excess of $1.5 billion in a wide variety of industries.
Haywood Securities Inc.
Fort House Inc.
MacFarlane Gordon Inc.
BMO Capital Markets
CIBC World Markets
Cormark Securities Inc.
Paradigm Capital Inc.
Sattva Capital Corp.
Haywood Securities Inc.
Brant Securities Inc.
Cormark Securities Inc.
Haywood Securities Inc.
Cornmark Securities
GMP Securities Inc.
Sprott Asset Management
Orion Securities Inc.
Connacord Adams
Casimir Capital
Haywood Securities Inc.
Sprott Asset Management
Orion Securities
Fort House Inc.
Haywood Securities Inc.
Jennings Capital Inc.
Pacific International Securities Inc.
Haywood Securities Inc.
Cormark Securities Inc.
CIBC World Markets Inc.
Paradigm Capital Inc.
BMO Nesbitt Burns
Jennings Capital Inc.
Brant Securities Inc.
Haywood Securities Inc.
Paradigm Capital Inc.
Haywood Securities Inc.
PowerOne Financial
Numus Capital Corp.
PowerOne Capital Markets
Beacon Securities Ltd.
Blackmont Capital Group
Cormark Securities Inc.
Primary Capital Inc.
Kneat.com, inc. allows regulated organizations to move from paper-based validation to intelligent, digitized, and paperless solutions. They provide expert, up-to-date, in-depth, and reliable knowledge and services about easy implementation of GMP solutions. Numus coordinated the public listing of Kneat on the TSX-CV via a reverse takeover in June of 2016. Numus subsequently raised $ 1.6 million for Kneat at a price of $0.90 per share and $2.2 million at $1.05. Since the public listing, Numus has coordinated multiple private placements for the company. Since the transaction, Kneat’s software was onboarded by 7 of the top 10 largest pharmaceutical companies globally and recurring revenue has growing rapidly. The stock has returned over 500% since the company went public on July 5 2016. Since the transaction, Kneat has raised $X total.
Indicate your interest to invest with us in upcoming opportunities